Alpine Immune Sciences Inc (DELISTED) (ALPN:DL)
64.97
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
Alpine Immune Sciences Profit Margin (Quarterly): -254.8% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -254.8% |
December 31, 2023 | 19.32% |
September 30, 2023 | -116.7% |
June 30, 2023 | -153.1% |
March 31, 2023 | -141.3% |
December 31, 2022 | -679.5% |
September 30, 2022 | -158.6% |
June 30, 2022 | -342.0% |
March 31, 2022 | -55.23% |
December 31, 2021 | -334.8% |
September 30, 2021 | -158.5% |
June 30, 2021 | -153.3% |
March 31, 2021 | -332.2% |
Date | Value |
---|---|
December 31, 2020 | -112.4% |
September 30, 2020 | -320.8% |
June 30, 2020 | -1.44K% |
March 31, 2020 | -507.1% |
December 31, 2019 | -694.6% |
September 30, 2019 | -3.97K% |
June 30, 2019 | -2.09K% |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | -2.03K% |
March 31, 2018 | -1.68K% |
December 31, 2017 | -3.37K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.97K%
Minimum
Sep 2019
19.32%
Maximum
Dec 2023
-600.0%
Average
-287.8%
Median
Profit Margin (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 40.87% |
Eliem Therapeutics Inc | -- |
Regeneron Pharmaceuticals Inc | 22.96% |
Vera Therapeutics Inc | -- |
Eyenovia Inc | -218.7K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -15.86% |
Return on Assets | -12.21% |
Return on Invested Capital | -15.83% |
Operating Margin (Quarterly) | -322.8% |
Return on Net Operating Assets | -278.5% |